Infectious Disease

• In the Journals

• SVR more dependent on adherence to treatment duration than dosing interval

• June 19, 2013
• Patients with chronic hepatitis C genotype 1 had higher sustained virologic response rates with better treatment duration adherence, while adherence to...More »

• Meeting News Coverage Video

• Fecal microbiota transplantation effective for severe, complicated C. difficile infection

• June 18, 2013
• ORLANDO, Fla. — Olga C. Aroniadis, MD, gastroenterology fellow at Montefiore Medical Center in New York, discusses her presentation, “Long-Term...More »

• Infections tied to mood disorders

• June 18, 2013
• Autoimmune diseases and infections increased the risk for developing mood disorders, new data suggest. Researchers said hospital contacts with infections...More »

• Fecal microbiota transplantation effective for severe complicated C difficile infection

• June 18, 2013
• ORLANDO, Fla. — Olga C. Aroniadis, MD, gastroenterology fellow at Montefiore Medical Center in New York, discusses her presentation, “Long-Term Follow-up ......More »

• In the Journals

• Patients with HCV, occult HBV at greater risk for mortality, HCC, cirrhosis

• June 17, 2013
• Patients coinfected with chronic hepatitis C and occult hepatitis B were more likely to develop cirrhosis or hepatocellular carcinoma and had poorer...More »

• In the Journals

• Monovalent rotavirus vaccine highly effective against disease

• June 17, 2013
• During the first 2 years of life, the monovalent rotavirus vaccine was highly effective against severe rotavirus disease in US children, according to...More »

• In the Journals

• No impact on acute rejection from interferon/ribavirin HCV therapy among renal transplant recipients

• June 14, 2013
• Chronic hepatitis C-infected renal transplant recipients receiving interferon-based therapy experienced modest efficacy rates but were not at elevated...More »

• In the Journals

• Global rotavirus network increased surveillance capacity

• June 14, 2013
• To help reduce mortality and morbidity associated with rotavirus, WHO recommends that all countries include the rotavirus vaccine into their national...More »

• Meeting News Coverage Video

• Future HCV therapies will improve SVR rates, treatment durations, tolerability

• June 13, 2013
• ORLANDO, Fla. — Anna S. Lok, MD, professor of internal medicine at the University of Michigan in Ann Arbor, Mich., discusses upcoming advancements...More »

• In the Journals

• Interferon-based therapy benefited HCV/HIV coinfected patients despite viral relapse

• June 12, 2013
• Patients with HCV/HIV coinfection who experienced viral relapse after treatment with interferon-based therapy still experienced some clinical benefit,...More »

Personalize your page!

Register for Healio to get content tailored to your specialty and areas of interest. It’s FREE and only takes one minute. Register now!